Headache is one of the most common symptoms in the general population, but despite its high prevalence and impairment, migraine is often not recognized or effectively treated. To understand the appropriate and cost-effective use of novel treatments for migraine headaches, AMCP convened an expert forum of stakeholders.
Partnership Forum: Participants considered the possible solutions for addressing rising costs and discussed challenges, practical steps for implementing point of sale rebates and other proposed solutions, and discussed how patient assistance programs and copay policies fit into the affordability equation. This forum will develop recommendations and possible solutions to improve price transparency, address the rising costs of medications, and help patient understand and manage drug cost.
Partnership Forum: This forum made recommendations and considerations for ways that benefit design and reimbursement may evolve without compromising patient access and care.
Partnership Forum: Participants discussed how digital therapeutics with web and designed based applications are emerging as a means to treat conditions by engaging people to improve health and wellness.
Partnership Forum: Participants examined how to improve decision making for prior authorization and step therapy based on current market dynamics and considerations to ensure patients receive the most appropriate medications.
Partnership Forum: This Forum brought together industry leaders to consider P&T practices that reflect the current health care system and provide recommendations to allow for a transparent P&T process in today’s health care system.
